Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biomed Res Int ; 2015: 137097, 2015.
Article in English | MEDLINE | ID: mdl-26339588

ABSTRACT

The omega-3 polyunsaturated fatty acids (ω-3 PUFAs) are a class of lipids that has been shown to have beneficial effects on some chronic degenerative diseases such as cardiovascular diseases, rheumatoid arthritis, inflammatory disorders, diabetes, and cancer. Among ω-3 polyunsaturated fatty acids (PUFAs), docosahexaenoic acid (DHA) has received particular attention for its antiproliferative, proapoptotic, antiangiogenetic, anti-invasion, and antimetastatic properties, even though the involved molecular mechanisms are not well understood. Recently, some in vitro studies showed that DHA promotes the inhibition of glycolytic enzymes and the Warburg phenotype. For example, it was shown that in breast cancer cell lines the modulation of bioenergetic functions is due to the capacity of DHA to activate the AMPK signalling and negatively regulate the HIF-1α functions. Taking into account these considerations, this review is focused on current knowledge concerning the role of DHA in interfering with cancer cell metabolism; this could be considered a further mechanism by which DHA inhibits cancer cell survival and progression.


Subject(s)
Diet , Docosahexaenoic Acids/metabolism , Fatty Acids, Omega-3/metabolism , Neoplasms/metabolism , AMP-Activated Protein Kinases/biosynthesis , Apoptosis/drug effects , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Docosahexaenoic Acids/administration & dosage , Fatty Acids, Omega-3/administration & dosage , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/biosynthesis , Neoplasms/diet therapy , Neoplasms/genetics
2.
Food Chem ; 165: 232-40, 2014 Dec 15.
Article in English | MEDLINE | ID: mdl-25038671

ABSTRACT

In this study, chia seed flour, which is rich in omega-3 alpha-linolenic acid, and common and tartary buckwheat flour, which has a high antioxidant activity, were integrated into different types of bread with the aim of improving their nutritional value and healthy features. Our results indicate that bread made with chia and tartary buckwheat flour was more acceptable in many nutritional aspects compared to the control (common wheat bread); it contained a higher amount of protein (20%), insoluble dietary fibres (74%), ash (51%), and alpha-linolenic acid (67.4%). Moreover, this bread possessed lower energy (14%) and carbohydrate contents (24%) compared to the control. Tartary buckwheat also improved the total antioxidant capacity of the bread (about 75%) and provided a considerable amount of flavonoids, which are healthy non-nutritional compounds. Overall, chia and tartary buckwheat represent excellent raw materials for the formulation of gluten-free bread with high nutritional value.


Subject(s)
Bread/analysis , Fagopyrum/chemistry , Fatty Acids, Omega-3/analysis , Flavonoids/analysis , Flour/analysis , Glutens/chemistry , Dietary Fiber/analysis , Nutritive Value , Seeds/chemistry
3.
Biomed Res Int ; 2013: 310186, 2013.
Article in English | MEDLINE | ID: mdl-23762838

ABSTRACT

ω -3 Polyunsaturated fatty acids (PUFAs), mainly present in fish oil, are part of the human diet. Among PUFAs, docosahexaenoic acid (DHA) has received particular attention for its anti-inflammatory, antiproliferative, proapoptotic, antiangiogenetic, anti-invasion, and antimetastatic properties. These data suggest that DHA can exert antitumor activity potentially representing an effective adjuvant in cancer chemotherapy. This review is focused on current knowledge supporting the potential use of DHA for the enhancement of the efficacy of anticancer treatments in relation to its ability to enhance the uptake of anticancer drugs, regulate the oxidative status of tumor cells, and inhibit tumor cell invasion and metastasis.


Subject(s)
Adjuvants, Pharmaceutic/therapeutic use , Docosahexaenoic Acids/therapeutic use , Neoplasms/drug therapy , Adjuvants, Pharmaceutic/pharmacology , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Docosahexaenoic Acids/pharmacology , Humans , Neoplasm Metastasis , Neoplasms/pathology , Oxidative Stress/drug effects
4.
Cell Stress Chaperones ; 18(6): 801-8, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23580156

ABSTRACT

Few conventional cytotoxic anticancer therapeutics induce immunogenic cell death (ICD). This means that they induce tumor cells to undergo apoptosis while eliciting the emission of a spatiotemporal-defined combination of damage-associated molecular patterns (DAMPs) decoded by the immune system to activate antitumor immunity effective for long-term therapeutic success. The neurotoxin capsaicin (CPS) can induce both cancer cell apoptosis and immune-mediated tumor regression. In the present study, we investigated whether CPS is capable of eliciting the emission of ICD hallmarks in human bladder cancer cell lines undergoing apoptosis. We demonstrated that CPS induces pre- and early apoptotic cell surface exposure of calreticulin (CRT), HSP90, and HSP70 as well as ATP release. Moreover, CRT exposure was prevented by inhibition of endoplasmic reticulum-Golgi traffic by brefeldin A. Furthermore, high-mobility group box 1, HSP90, and HSP70 were passively released at late apoptotic stages. We provide the first evidence that CPS is an inducer of ICD hallmarks, suggesting CPS as a novel potential immunogenic cytotoxic agent.


Subject(s)
Apoptosis/drug effects , Capsaicin/toxicity , Immune System/metabolism , Adenosine Triphosphate/metabolism , Antineoplastic Agents/toxicity , Brefeldin A/antagonists & inhibitors , Brefeldin A/metabolism , Calreticulin/metabolism , Cell Line, Tumor , HMGB1 Protein/metabolism , HSP70 Heat-Shock Proteins/metabolism , HSP90 Heat-Shock Proteins/metabolism , Humans , Immune System/drug effects , Urinary Bladder Neoplasms/immunology , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/pathology
5.
J Nutr Biochem ; 23(5): 452-7, 2012 May.
Article in English | MEDLINE | ID: mdl-21684140

ABSTRACT

Fish oil-derived n-3 polyunsaturated fatty acids (n-3 PUFAs) inhibit invasion of some tumor cell types in vitro and in vivo. The mechanisms underlying this activity are unclear. Here, we examined the capability of n-3 PUFA-docosahexaenoic acid (22:6n-3; DHA) to affect the invasiveness of human RT112 urinary bladder and PT45 pancreatic carcinoma cell lines in vitro and the mechanism underlying this activity; n-6 PUFA-arachidonic acid (20:4n-6; AA) served as control. We showed that, in contrast to AA, 25, 50 and 100 µM DHA significantly inhibited in a dose-dependent manner the invasion through Matrigel of both RT112 and PT45 cells. Then, we analyzed whether the serine proteinase granzyme B (GrB), originally known as cytotoxic molecule of lymphocytes and recently also characterized for its extracellular functions such as invasion promotion of bladder cancer cells, might be involved in the invasion inhibitory activity exerted by DHA. We demonstrated that, accordingly to RT112 bladder cancer cells, PT45 cells expressed GrB and GrB promoted their invasion, since stealth RNA interference-mediated down-regulation of GrB dramatically suppressed PT45 cell invasion. Notably, we also showed that, in contrast to AA, 25, 50 and 100 µM DHA induced a dose-dependent down-modulation of GrB expression in both RT112 and PT45 cells. In conclusion, DHA can reduce the invasive phenotype of bladder and pancreatic carcinoma cells, and we provide the first evidence for a possible causative role of GrB in DHA-induced inhibition of cancer cell invasion. The potential use of fish oil as adjuvant antibladder and antipancreatic cancer agent may be suggested.


Subject(s)
Docosahexaenoic Acids/pharmacology , Down-Regulation , Granzymes/genetics , Pancreatic Neoplasms/pathology , Urinary Bladder/pathology , Fatty Acids, Unsaturated/pharmacology , Gene Expression Regulation, Neoplastic , Granzymes/metabolism , Humans , Neoplasm Invasiveness , Pancreatic Neoplasms/metabolism , RNA Interference , Tumor Cells, Cultured , Urinary Bladder/metabolism
6.
Cancer Immunol Immunother ; 60(10): 1503-7, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21779875

ABSTRACT

Some anticancer chemotherapeutics, such as anthracyclines and oxaliplatin, elicit immunogenic apoptosis, meaning that dying cancer cells are engulfed by dendritic cells and tumor antigens are efficiently presented to CD8+ T cells, which control residual tumor cells. Immunogenic apoptosis is characterized by pre-apoptotic cell surface exposure of calreticulin (CRT), which usually resides into the endoplasmic reticulum. We investigated the ability of the n3-polyunsaturated fatty acid docosahexaenoic acid (22:6n3, DHA) to induce pre-apoptotic CRT exposure on the surface of the human PaCa-44 pancreatic and EJ bladder cancer cell lines. Cells were treated with 150 µM DHA for different time periods, and, by immunoblot and immunofluorescence, we showed that DHA induced CRT exposure, before the apoptosis-associated phosphatidylserine exposure. As for the known immunogenic compounds, CRT exposure was inhibited by the antioxidant GSH, the pan-caspase zVAD-FMK, and caspase-8 IETD-FMK inhibitor. We provide the first evidence that DHA induces CRT exposure, representing thus a novel potential anticancer immunogenic chemotherapeutic agent.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Calreticulin/metabolism , Docosahexaenoic Acids/pharmacology , Antineoplastic Agents/immunology , Apoptosis/immunology , Calreticulin/immunology , Cell Line, Tumor , Cell Separation , Docosahexaenoic Acids/immunology , Flow Cytometry , Humans , Immunoblotting
SELECTION OF CITATIONS
SEARCH DETAIL
...